XBIO Xenetic Biosciences, Inc. - Common Stock

NASDAQ · Biotechnology · SEC EDGAR에서 보기 ↗
$2.90
가격 · 5월 19, 2026
기준 재무 정보 5월 12, 2026

XBIO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

가격
$2.90
시가총액
P/E (TTM)
-1.4
EPS (TTM)
$-1.58
매출 (TTM)
$3M
배당 수익률
ROE
부채/자본
52주 범위
$2 – $14

XBIO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

10년 성과 매출, 순이익, 마진 및 EPS 추세

매출 및 순이익 $3M
10-point trend, -0.8%
2016-12-31 2025-12-31
EPS $-1.58
5-point trend, -187.3%
2021-12-31 2025-12-31
잉여현금흐름
마진

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표
5년 추세
XBIO
동종업계 중앙값
P/E (TTM)
5-point trend, +94.1%
-1.4

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표
5년 추세
XBIO
동종업계 중앙값

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표
5년 추세
XBIO
동종업계 중앙값

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표
5년 추세
XBIO
동종업계 중앙값
Revenue YoY (매출 YoY)
5-point trend, +156.4%
19.0%
Revenue CAGR 3Y (매출 CAGR 3년)
5-point trend, +156.4%
20.4%
Revenue CAGR 5Y (매출 CAGR 5년)
5-point trend, +156.4%
46.8%

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표
5년 추세
XBIO
동종업계 중앙값
EPS (Diluted) (EPS (희석))
5-point trend, -187.3%
$-1.58

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표
5년 추세
XBIO
동종업계 중앙값

XBIO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

매도 6 명의 애널리스트
  • 적극 매수 0 0.0%
  • 매수 0 0.0%
  • 보유 3 50.0%
  • 매도 1 16.7%
  • 적극 매도 2 33.3%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

평균 서프라이즈
-0.07%
기간 EPS Actual EPS 예상 서프라이즈
2025년 6월 30일 $-0.45 $-0.65 0.20%
2025년 3월 31일 $-0.59 $-0.73 0.14%
2024년 12월 31일 $-0.68 $-0.20 -0.48%
2024년 9월 30일 $-0.28 $-0.14 -0.14%

동료 비교 주요 지표 대 섹터 동종 기업

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
XBIO -1.4 19.0%
ACXP $6M -0.5 -180.3%
BIAF
GOVX $296.2K -37.1% -862.3% -645.9%
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%
BCAB -0.6
APVO $9M -0.1 -217.2%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

손익계산서 17
XBIO의 연간 손익계산서 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +2976411.00 $3M $3M $3M $2M $1M $436.9K $17.1K $0 $8M $3M $0 $0
Cost of Revenue · · · · · · · · · · · $0
Gross Profit · · · · · · · · · · · $0
R&D Expense 12-point trend, -51.5% $3M $3M $3M $5M $3M $2M $5M $3M $4M $44M $3M $6M
SG&A Expense 12-point trend, -58.4% $3M $3M $4M $4M $4M $3M $5M $4M $7M $7M $6M $7M
Operating Expenses 9-point trend, -55.0% $6M $7M $7M $8M $7M $14M $13M $7M · · · $13M
Operating Income 12-point trend, +78.1% $-3M $-4M $-5M $-7M $-6M $-14M $-13M $-7M $-4M $-47M $-10M $-13M
Interest Expense 4-point trend, -61.4% · · · · · · · · $1.8K $729.6K $267.0K $4.7K
Interest Income · · · · · · · · · · · $19.0K
Other Non-op 12-point trend, +101.8% $5.7K $-5.7K $25.4K $-1.6K $1.1K $-492 $3.3K $-24.6K $-24.6K $-85.4K $-235.4K $-326.9K
Pretax Income · · · · · · · · · · · $-14M
Income Tax 12-point trend, +0.00 $0 $0 $0 $0 $0 $-3M $0 $0 $0 $0 $0 $0
Net Income 12-point trend, +81.3% $-3M $-4M $-4M $-7M $-6M $-11M $-13M $-7M $-4M $-54M $-13M $-14M
EPS (Basic) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
EPS (Diluted) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
Shares (Basic) 5-point trend, -83.4% 1,701,571 1,541,339 1,528,210 1,422,443 10,279,408 · · · · · · ·
Shares (Diluted) 5-point trend, -83.4% 1,701,571 1,541,339 1,528,210 1,422,443 10,279,408 · · · · · · ·
대차대조표 25
XBIO의 연간 대차대조표 데이터
지표 추세 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +214.4% $8M $6M $9M $13M $18M $12M $10M $571.6K $6M $4M $132.2K $3M
Receivables 3-point trend, +0.00 · · · · · · · · $0 $3M $0 ·
Prepaid Expense 12-point trend, -18.5% $166.3K $422.0K $603.8K $556.1K $479.4K $842.0K $722.1K $555.9K $285.0K $1M $247.3K $204.0K
Current Assets 12-point trend, +189.8% $8M $7M $10M $14M $19M $12M $11M $1M $6M $8M $4M $3M
PP&E (Net) 9-point trend, -100.0% · · · $0 $0 $0 $757 $5.0K $27.8K $42.4K $62.0K $119.4K
PP&E (Gross) 9-point trend, -100.0% · · · $0 $50.2K $57.0K $57.0K $89.4K $358.3K $349.1K $332.3K $586.1K
Accum. Depreciation 9-point trend, -100.0% · · · $0 $50.2K $57.0K $56.3K $84.4K $330.5K $306.7K $270.2K $466.7K
Goodwill 7-point trend, -100.0% · · · · · $0 $9M $3M $3M $3M $3M $3M
Other Non-current Assets 12-point trend, +57.5% $313.9K $313.9K $1M $1M $1M $810.0K $1M $705.7K $724.7K $66.3K $129.3K $199.3K
Total Assets 12-point trend, -48.7% $8M $7M $11M $15M $20M $13M $22M $14M $19M $21M $17M $16M
Accounts Payable 12-point trend, -69.7% $258.1K $283.6K $240.8K $287.4K $362.5K $327.4K $931.1K $934.1K $786.8K $1M $2M $852.8K
Accrued Liabilities 12-point trend, -49.6% $709.9K $610.6K $568.8K $785.8K $1M $574.0K $464.0K $664.0K $1M $838.9K $1M $1M
Current Liabilities 12-point trend, -64.1% $968.0K $894.3K $809.6K $1M $1M $936.9K $1M $2M $2M $2M $7M $3M
Capital Leases 2-point trend, +27043.00 · · · · · $27.0K $0 · · · · ·
Deferred Tax 7-point trend, -99.1% · · · · · $27.0K $3M $3M $3M $3M $3M $3M
Other Non-current Liabilities 5-point trend, -100.0% · · · · · · · $0 $0 $19.9K $38.8K $56.4K
Total Liabilities 12-point trend, -83.4% $968.0K $894.3K $809.6K $1M $1M $964.0K $4M $5M $5M $5M $10M $6M
Common Stock 12-point trend, -98.5% $2.3K $1.5K $1.5K $1.5K $13.5K $8.8K $6.1K $811 $9.0K $8.7K $4.9K $150.0K
Paid-in Capital 12-point trend, +134.2% $212M $208M $208M $208M $206M $194M $188M $168M $165M $164M $100M $91M
Retained Earnings 12-point trend, -164.3% $-200M $-197M $-193M $-189M $-183M $-177M $-166M $-153M $-146M $-142M $-88M $-76M
Treasury Stock Flat — no change across 12 periods $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M
AOCI 12-point trend, -55.9% $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $575.7K
Stockholders' Equity 12-point trend, -29.4% $7M $6M $10M $14M $18M $12M $17M $10M $14M $16M $7M $10M
Liabilities + Equity 12-point trend, -48.7% $8M $7M $11M $15M $20M $13M $22M $14M $19M $21M $17M $16M
Shares Outstanding 12-point trend, -98.4% 2,291,056 1,542,139 1,540,684 1,516,659 13,439,612 8,745,207 6,065,441 783,865 8,717,541 4,585,800 4,585,800 139,297,282
현금 흐름 8
XBIO의 연간 현금 흐름 데이터
지표 추세 202520242023202220212020201920182017201620152014
D&A 5-point trend, -100.0% · · · $0 $0 $1.0K · · · · $56.1K $88.7K
Stock-based Comp 12-point trend, -95.7% $64.8K $171.8K $283.1K $511.5K $410.4K $468.9K $806.1K $1M $2M $2M $2M $2M
Operating Cash Flow 12-point trend, +82.0% $-2M $-3M $-4M $-5M $-5M $-4M $-6M $-6M $1M $-9M $-5M $-13M
CapEx 5-point trend, -100.0% · · · · · · · $0 $9.3K $16.8K $1.7K $57.7K
Investing Cash Flow 8-point trend, +100.0% · · $0 $-500.0K $0 $0 $2.0K $22.5K $-9.3K $-16.8K · ·
Stock Issued 8-point trend, -60.0% $4M $0 · $0 $11M $5M $0 · · · $0 $10M
Financing Cash Flow 9-point trend, -68.5% $4M $0 · $0 $11M $5M $16M $1M $0 $13M · ·
Taxes Paid · · · · · · · · · · · $0
주당 1
XBIO의 연간 주당 데이터
지표 추세 202520242023202220212020201920182017201620152014
EPS (TTM) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
성장률 3
XBIO의 연간 성장률 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -88.5% 19.0% -1.6% 48.8% 47.1% 165.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -74.5% 20.4% 29.1% 79.8% · · · · · · · · ·
Revenue CAGR 5Y 46.8% · · · · · · · · · · ·
가치 평가 (TTM) 5
XBIO의 연간 가치 평가 (TTM) 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +2976411.00 $3M $3M $3M $2M $1M $436.9K $17.1K $0 $8M $3M $0 $0
Net Income TTM 12-point trend, +81.3% $-3M $-4M $-4M $-7M $-6M $-11M $-13M $-7M $-4M $-54M $-13M $-14M
P/E 5-point trend, +94.1% -1.4 -1.6 -1.3 -0.6 -23.5 · · · · · · ·
P / Tangible Book 6-point trend, -95.4% 0.7 1.0 0.5 3.2 9.4 14.6 · · · · · ·
Earnings Yield 5-point trend, -1609.2% -72.8% -64.4% -78.5% -161.8% -4.3% · · · · · · ·

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

손익계산서
2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $3M$3M$3M$2M$1M
순이익 $-3M$-4M$-4M$-7M$-6M
희석 EPS $-1.58$-2.57$-2.71$-4.61$-0.55

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

📊

중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.